An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a public forum described being on Mounjaro (a prescription weight-loss/type 2 diabetes drug) for about two months and wondered whether they should increase their dose. They’ve had around eight injections so far: four at 2.5 mg and four at 5 mg. Their starting weight was about 142.6 kg and now they’re 137.4 kg, so they’ve lost a bit of weight, but they say their appetite hasn’t really changed except for a short “pressed” feeling in the stomach for about a day after the lower dose. Mounjaro is the brand name for tirzepatide. In plain terms, tirzepatide is a lab-made molecule that acts like two natural gut hormones that help control blood sugar and appetite. Those hormones normally tell your brain you’re full and help slow how fast your stomach empties after a meal. A “dose” means how much of the drug someone injects at a time; higher doses often cause stronger effects but can also increase side effects. What the snippet shows is just one person’s experience, not a controlled study. They’ve lost about 5.2 kg (roughly 11.5 pounds) in two months, which is a reasonable amount but not dramatic. They report only a temporary change in stomach feeling at the lower dose and otherwise little appetite suppression. That’s useful as an anecdote, but it doesn’t prove what will happen for others. Clinical trials of tirzepatide used many more people and showed larger average weight loss at higher doses, but individual responses vary a lot. Why this matters: people taking tirzepatide/Mounjaro often want to know whether increasing the dose will speed weight loss or reduce hunger. If someone is not getting the appetite or weight effects they hoped for, they might think a higher dose could help. Doctors typically weigh the potential extra benefit against the risk of side effects and follow a dosing schedule used in trials. So this forum post is the kind of real-world feedback you’ll see—but it’s not a substitute for medical advice. Important caveats: tirzepatide can cause nausea, vomiting, diarrhea, abdominal pain, and other side effects that are more common at higher doses. Some people can’t take it because of personal health issues or drug interactions. Only a prescribing clinician can safely recommend a dose change; they’ll consider medical history, blood sugar, other meds, and side effects. Also, a short two-month window is early: it can take longer to see steady appetite or weight changes, and stopping or changing the dose without guidance can be risky. Bottom line: one person’s modest weight loss and unchanged appetite after two months on Mounjaro doesn’t prove a higher dose will help them—or you. Talk to the prescriber about goals, side effects, and whether a dose adjustment is appropriate.
Source: r/Mounjaro